A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder

Clinical trial NCT00195845 · COMPLETED

Trial details

NCT number: NCT00195845
Sponsor: Cambridge Health Alliance
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2003-04-01
Primary completion: 2006-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.